Literature DB >> 7482964

Time is of the essence: the pressing need for comprehensive non-heart-beating cadaveric donation policies.

R M Arnold1, S J Youngner.   

Abstract

Keywords:  Health Care and Public Health

Mesh:

Year:  1995        PMID: 7482964

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts.

Authors:  Paolo Muiesan; Raffaele Girlanda; Wayel Jassem; Hector Vilca Melendez; John O'Grady; Matthew Bowles; Mohamed Rela; Nigel Heaton
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

2.  Non-heart beating organ donation: old procurement strategy--new ethical problems.

Authors:  M D D Bell
Journal:  J Med Ethics       Date:  2003-06       Impact factor: 2.903

3.  In defense of the reverence of all life: Heideggerean dissolution of the ethical challenges of organ donation after circulatory determination of death.

Authors:  D J Isch
Journal:  Med Health Care Philos       Date:  2007-05-02

4.  Upregulation and protein trafficking of aquaporin-2 attenuate cold-induced osmotic damage during cryopreservation.

Authors:  Wenjun Wang; Robert N Ben
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Mar-Apr       Impact factor: 2.416

5.  The Benefits of Fibrinolysis Combined with Venous Systemic Oxygen Persufflation (VSOP) in a Rat Model of Donation after Circulatory Death and Orthotopic Liver Transplantation.

Authors:  Nadja Kröger; Zoltan Czigany; Jipin Jiang; Mamdouh Afify; Pascal Paschenda; Kazuyuki Nagai; Shintaro Yagi; René H Tolba
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 5.923

6.  Donor liver quality after hypovolemic shock and venous systemic oxygen persufflation in an experimental animal model.

Authors:  Azin Jafari; Hanno Matthaei; Vittorio Branchi; Edwin Bölke; Rene H Tolba; Jörg C Kalff; Steffen Manekeller
Journal:  Eur J Med Res       Date:  2018-10-23       Impact factor: 2.175

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.